MYLIP and type 2 diabetes mellitus: We have measured the expression of IDOL in CD14+ monocytes in subjects with and without type 2 diabetes and shown that IDOL expression in CD14+ monocytes was significantly reduced in individuals with diabetes compared with healthy nondiabetic control.